Tempus Provider vs ASCO
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Tempus Provider
This app provides oncology providers with quick and secure access to patient reports, including genomic variants and immunotherapy markers. It features advanced search, real-time order tracking, and clinical decision support tools to help match patients with treatments and trials.
- Next-generation sequencing results
- Genomic variants and immunotherapy markers
- Clinical decision support tools
- Treatment implications and clinical trials
- Patient clinical timeline
- Secure access with Touch/Face ID
- Push notifications for new reports
Read full descriptionHide full description
The Tempus mobile app gives oncology providers fast and reliable access to patient reports, advanced patient search, and real-time order tracking. View interactive and in-depth patient results with: - Next-generation sequencing results including genomic variants and immunotherapy markers - Sortable and filterable clinical decision support tools including treatment implications and clinical trial(s) matched to patient's clinical and molecular profile - Comprehensive gene descriptions paired with matched therapies - Quick access to your patient’s structured clinical timeline - PDF of your full Tempus report all within the app - Access your patient's data quickly and securely with Touch ID or Face ID - Instantly know when a new report is available via push notifications - Check the status of an order from receipt of specimens through sequencing and report delivery
ASCO
Read full descriptionHide full description
The new ASCO App is a trusted tool for ASCO Members and the oncology community. Get a personalized feed of practice-changing science from JCO Journals tailored to your specialty, streamline your membership, and access professional development tools like ASCO-SEP®—anytime, anywhere. It’s an essential resource designed to save you time while fostering continuous engagement with the global oncology community.
Screenshots
Verdict
The clearest difference is update cadence: ASCO at fortnightly against Tempus Provider's every 6 weeks. ASCO also leads on iOS requirement (16 vs 18.0). On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Tempus Provider ships an update every 6 weeks, ASCO fortnightly. The most recent releases landed on November 11, 2026 and October 30, 2026 respectively.
| Parameter | Tempus Provider | ASCO |
|---|---|---|
| Price | Free | Free |
| Rating | 5.0 (21 ratings) — better | — |
| Number of ratings | 21 — better | — |
| Update frequency | Every 6 weeks | Fortnightly — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPhone, iPad | iPhone, iPad, iPod — better |
| Requires iOS | 18.0 | 16 — better |
| Further details — not scored | ||
| Size | 50 MB | 87 MB |
| Age rating | 17+ | 17+ |
| Developer | Tempus AI, Inc. | American Society of Clinical Oncology |
In-app purchases
Tempus Provider
No in-app purchases
ASCO
No in-app purchases








